Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
STZ causes depletion of immune cells in sciatic nerve and dorsal root ganglion in experimental diabetes.
J. Neuroimmunol. 306, 76-82 (2017)
Streptozotocin (STZ) treatment, a common model for inducing diabetes in rodent models, induces thermal hyperalgesia and neuronal toxicity independently of hyperglycemia by oxidizing and activating TRPA1 and TRPV1. Following treatment with STZ, CD45+ immune cells were found to be depleted in sciatic nerve (SN) and DRG in mice, prior to hyperglycemia. Macrophages were also lost in DRG and NFκB-p65-activation was increased in SN macrophages. Immune cells were significantly reduced in both SN and DRG up to three weeks, post-treatment. Loss of PNS-resident macrophages in response to STZ-mediated toxicity may affect the regenerative capacity of the nerve in response to further injury caused by diabetes.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Diabetic Neuropathy ; Experimental Diabetes ; Macrophage ; Neurotoxicity; Thermal Hyperalgesia; Scavenger-receptor; Sensitive Method; Spinal-cord; Streptozotocin; Macrophages; Neuropathy; Pain; Regeneration; Expression
ISSN (print) / ISBN
0165-5728
e-ISSN
1872-8421
Zeitschrift
Journal of Neuroimmunology
Quellenangaben
Band: 306,
Seiten: 76-82
Verlag
Elsevier
Verlagsort
Amsterdam
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Diabetes and Cancer (IDC)